Sobi Inc. Company Profile

01:53 EDT 23rd April 2018 | BioPortfolio

News Articles [42 Associated News Articles listed on BioPortfolio]

Invitation - Presentation of Sobi's Q4/FY 2017 Results

The presentation can be followed live, or afterwards on Slides used in the presentation will be made available on Sobi's website prior to Read more...

Sobi enrols first patient in Phase III trial for Still’s disease

Swedish Orphan Biovitrum (Sobi) has started patient enrolment in the Phase III anaSTILLs clinical trial of Kineret (anakinra) for Still’s...Read More... The post Sobi enrols first patient in Phase I...

Sobi värvar chef från Pfizer

Fredrik Wetterlundh blir ny HR-chef på Sobi.

Sobi receives approval for Orfadin to treat HT-1 patients in Canada

Swedish Orphan Biovitrum (Sobi) has received approval from Health Canada for an oral suspension formulation of Orfadin (nitisinone) to treat...Read More... The post Sobi receives approval for Orfadin ...

EU expands indications for Sobi's Kineret

European regulators expanded treatment indications for Sobi's Kineret, or anakinra, to treat the rare auto-inflammatory disor -More- 

EU regulators expand reach of Sobi’s Kineret

European regulators have expanded the scope of Sobi’s Kineret to include the treatment of Still’s disease, a rare, systemic, multi-organ, auto-inflammatory disorder that affects around 25,...

Ireland procures Sobi therapies for all haemophilia patients

The Republic of Ireland has become the first country in Europe to switch its entire population with haemophilia A and B treated with short-acting replacement clotting factors to Swedish Orphan Biovitr...

Sobi’s metabolic disorder drug secures fast track status in US

The US Food and Drug Administration (FDA) has accepted Swedish Orphan Biovitrum's (Sobi) new drug application and granted fast track status for mucopolysaccharidosis type IIIA (MPS IIIA) drug candidat...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [6 Associated Companies listed on BioPortfolio]

Swedish Orphan Biovitrum AB

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. Sobi have a diversi...


Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the li...

Sobi Inc.

Biogen and Sobi

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare ...

Bioverativ Inc. & Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class re...

More Information about "Sobi Inc." on BioPortfolio

We have published hundreds of Sobi Inc. news stories on BioPortfolio along with dozens of Sobi Inc. Clinical Trials and PubMed Articles about Sobi Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sobi Inc. Companies in our database. You can also find out about relevant Sobi Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record